Generic Name: fondaparinux
Applies to fondaparinux: subcutaneous solution
In addition to its needed effects, some unwanted effects may be caused by fondaparinux (the active ingredient contained in Arixtra). In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking fondaparinux:

If any of the following symptoms of overdose occur while taking fondaparinux, get emergency help immediately:

Some of the side effects that can occur with fondaparinux may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to fondaparinux: subcutaneous solution
The most common adverse events were bleeding events.The most serious adverse events were bleeding complications and thrombocytopenia.[Ref]
Very common (10% or more): Anemia (19.6%)Common (1% to 10%): Post-operative hemorrhage, major bleeding, minor bleeding, moderate thrombocytopenia, non-fatal major bleeding at surgical site, overt bleeding associated with a bleeding index of 2 or greater, prothrombin decreased, other clinically overt bleeding, bleedingUncommon (0.1% to 1%): Reoperation due to bleeding, non-fatal major bleeding at non-surgical site, severe thrombocytopenia, fatal bleeding, intracranial bleeding, thrombocythemia, abnormal platelets, coagulation disorder Very rare (less than 0.01%): Hypertensive encephalopathy with intracranial bleeding, minor gastrointestinal bleedingPostmarketing reports: Thrombocytopenia with thrombosis, aPTT elevation, intracerebral bleeding, retroperitoneal bleeding[Ref]
The majority of major bleeding events occurred during the first 4 days after surgery.  Major bleeding incidence increased in patients weighing less than 50 kg and in patients with impaired renal function.[Ref]
Very common (10% or more): Fever (13.6%)Common (1% to 10%): Edema, post-operative wound infection, wound drainage increased, surgical site reaction, pain, chest painUncommon (0.1% to 1%): Edema peripheral, wound secretionRare (less than 0.1%): Hot flushes[Ref]
Very common (10% or more): Nausea (11.3%)Common (1% to 10%): Constipation, vomiting, diarrhea, dyspepsia, abdominal painRare (less than 0.1%): Gastritis[Ref]
Common (1% to 10%): Hematoma, bruisingRare (less than 0.1%): Injection site reactionFrequency not reported: Local irritation (injection site bleeding, rash, pruritus)[Ref]
Common (1% to 10%): Increases in ALT, increases in ASTUncommon (0.1% to 1%): Hepatic function abnormal, hepatic enzymes increasedRare (less than 0.1%): BilirubinemiaFrequency not reported: Increases in bilirubin[Ref]
Common (1% to 10%): Hypotension, hypertension[Ref]
Common (1% to 10%): Rash, purpura, bullous eruption (includes localized blister)Uncommon (0.1% to 1%): PruritusRare (less than 0.1%): Flushing[Ref]
Common (1% to 10%): Headache, dizziness Rare (less than 0.1%): Somnolence, vertigo, fatigue, syncopePostmarketing reports: Spinal or epidural hematoma[Ref]
Common (1% to 10%): Urinary tract infection, urinary retentionRare (less than 0.1%): Edema genital[Ref]
Common (1% to 10%): Hypokalemia[Ref]
Common (1% to 10%): Leg pain, back pain[Ref]
Common (1% to 10%): Insomnia, confusionUncommon (0.1% to 1%): Anxiety[Ref]
Common (1% to 10%): Pneumonia, coughing, epistaxisRare (less than 0.1%): Dyspnea[Ref]
Rare (less than 0.1%): Allergic reactionVery rare (less than 0.01%): Angioedema, anaphylactoid/anaphylactic reactionPostmarketing reports: Serious allergic reactions[Ref]
1. "Product Information. Arixtra (fondaparinux)." Organon, West Orange, NJ. 
2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
3. Cerner Multum,  Inc. "Australian Product Information." O 0
4. Warkentin TE,  Maurer BT,  Aster RH "Heparin-induced thrombocytopenia associated with fondaparinux." N Engl J Med 356 (2007): 2653-5; discussion 2653-5
5. Savi P,  Chong BH,  Greinacher A, et al. "Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies. A blinded comparative multicenter study with unfractionated heparin." Blood 105 (2005): 139-41
Not all side effects for Arixtra may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Pale skin
troubled breathing with exertion
unusual bleeding or bruising
unusual tiredness or weakness


Black, tarry stools
bladder pain
bleeding gums
blood in the urine or stools
blurred vision
chest pain
chills
collection of blood under the skin
confusion
convulsions
cough
decreased or cloudy urine
deep, dark purple bruise
difficult, burning, or painful urination
dizziness
dry mouth
fainting or lightheadedness when getting up from a lying or sitting position
fever
frequent urge to urinate
increased thirst
irregular heartbeat
itching, pain, redness, or swelling at the injection site
loss of appetite
lower back or side pain
muscle pain or cramps
nausea or vomiting
numbness or tingling in the hands, feet, or lips
pinpoint red spots on the skin
red, tender, or oozing skin at incision
shortness of breath
sore throat
sores, ulcers, or white spots on the lips or in the mouth
sudden sweating


Back pain
bowel or bladder dysfunction
difficulty with swallowing
fast heartbeat
hives, itching, or skin rash
large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
leg weakness
numbness
paralysis
puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
tightness in the chest


Abdominal or stomach pain or swelling
bruising or purple areas on the skin
coughing up blood
decreased alertness
headache
joint pain or swelling
nosebleeds


Difficulty having a bowel movement
swelling
trouble sleeping


Acid or sour stomach
belching
diarrhea
heartburn
indigestion
pain
skin blisters
stomach discomfort, upset, or pain
tightness in the chest
unusual changes to site of surgery
wound drainage, increased

